Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

E-Learning could make cancer care safer for patients in oman

NCT ID NCT07600853

Knowledge-focused Sponsor: Sultan Qaboos Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will develop and test an online training program for nurses who give powerful cancer drugs like chemotherapy. About 238 nurses from two cancer centers in Oman will take part. Half will get the e-learning course, and half will continue with usual training. Researchers will compare their knowledge, attitudes, and skills before and after the program to see if the online course helps them work more safely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
E-learning certification course
What this could lead to
If successful, this e-learning program could become a standard training tool to help nurses safely administer cancer treatments, improving patient care in Oman and beyond.
What could go wrong
This is an early-stage educational study with no direct patient treatment. The results may not apply to other hospitals or countries, and improvements in knowledge may not translate to real-world practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 238 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Nurses who are willing to participate in the study * Nurses who speaks and understand English. * Nurses who administer systemic anti-cancer treatment in oncology units. * Nurses who are administering systemic anticancer treatment to the adult oncology patient through IV piggyback * Nurses who are willing to attend the orientation meeting getting familiarity with the study purpose and e- learning module. * Nurses who completed baseline training in systemic anticancer therapy. Exclusion Criteria: * Nurses who are not willing to participate in the study * Nurses who are administering systemic anticancer therapy to the pediatric patients * Nurses who are administering systemic anticancer therapy to the non-oncology patient. * Nurses who are not completed baseline training in systemic anticancer therapy. * Nurses who are pregnant and breast feeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attitude are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior learning disability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attitude E-learning Knowledge Practice

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City

    Muscat, Seeb, 123, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.